Lipoprotein and Apolipoproteins With Metabolic Liver Diseases
NCT03220971 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 440
Last updated 2018-04-19
Summary
Theranostic translation applications against viral, metabolic liver diseases and hepatic oncogenesis: lipoprotein and apolipoproteins at a crossroad
Conditions
- Disorders of Lipoprotein Metabolism and Other Lipidaemias
Interventions
- OTHER
-
lipoprotein and apolipoproteins
To find out the role of lipoprotein and apolipoproteins (apos) in pathogenic hepatic diseases
Sponsors & Collaborators
-
Chun-Hsiang Wang
lead OTHER
Eligibility
- Min Age
- 20 Years
- Max Age
- 70 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2017-09-20
- Primary Completion
- 2019-10-31
- Completion
- 2019-10-31
Countries
- Taiwan
Study Locations
More Related Trials
-
Evaluation of Treatment Response With Integrated MRI/PET in Patients With Hepatocellular Carcinoma
NCT02550613 ·Status: UNKNOWN
-
Early Screening of Hepatocellular Carcinoma in Cirrhotic Patients: a Prospective Study
NCT00629421 ·Status: COMPLETED
-
Long-term Prognosis of Patients With Hepatitis B Related Acute-on-chronic Liver Failure
NCT04310787 ·Status: RECRUITING
-
Evaluation of Patients With Liver Disease
NCT00001971 ·Status: RECRUITING
-
Effectiveness and Safety of the COVID-19 Vaccination for Patients With Liver Disease (CHESS2101)
NCT04883177 ·Status: COMPLETED
-
Longitudinal Study of Mitochondrial Hepatopathies
NCT01148550 ·Status: SUSPENDED
-
Research on the Clinical Characteristics and Key Diagnosis and Treatment Technology of Genetic and Metabolic Liver Disease
NCT05601557 ·Status: UNKNOWN
-
Screening for Liver Cancer With CT vs. Ultrasound in Patients With Advanced Liver Disease
NCT01350167 ·Status: UNKNOWN ·Phase: NA
-
To Study the Effects of Host Genetic Factors on Liver Cirrhosis and Hepatocellular Carcinoma (HCC)
NCT00709085 ·Status: UNKNOWN
-
Prophylactic Treatment of Hepatic Dysplastic Nodules in HBsAg Positive Patients
NCT02793791 ·Status: UNKNOWN ·Phase: NA
-
The Utility of Cell-free Methylation Markers in Blood for Hepatocellular Carcinoma
NCT05576571 ·Status: UNKNOWN
-
Development of a Set of Auxiliary Decision-making System for the Perioperative Period of Hepatectomy Based on Static CT and Artificial Intelligence.
NCT07056270 ·Status: NOT_YET_RECRUITING
-
LEAF(Liver Tumor dEtection And classiFication AI)
NCT06859840 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA
-
Observational Clinical Study of the Natural Course and Long-term Prognosis of Patients With Chronic Liver Disease
NCT05653830 ·Status: RECRUITING
-
A Prospective Study of UCAD for Diagnosing Benign or Malignant Biliary Obstruction and Follow-up
NCT05237193 ·Status: UNKNOWN
-
By Developing a Radiomics Model to Predict the Prognosis of Patients With Hepatocellular Carcinoma After Microwave Ablation
NCT03880721 ·Status: UNKNOWN
-
Application of the Stem Cell Therapy in the End Stage Liver Disease and Assessment Its Consequences in the Quality of Live Style as Well as Development of HCC.
NCT01729221 ·Status: UNKNOWN
-
The Surveillance of Hepatocellular Carcinoma
NCT05286099 ·Status: UNKNOWN
-
A Prospective Study of ¹⁸F-DFA PET Imaging for the Assessment of Liver Injury
NCT07050550 ·Status: RECRUITING
-
Analysis of Methylomic Features and Prognostic Risk Prediction in Patients With Hepatitis B-related Acute-on-chronic Liver Failure
NCT07275554 ·Status: RECRUITING
-
Evaluating the Association Between Sphingolipid Metabolites and Post-hepatectomy Liver Failure
NCT03598465 ·Status: COMPLETED
-
Evaluation of Multi-Organ Metabolism and Perfusion in NAFLD by Total Body Dynamic PET Scan on EXPLORER
NCT04165343 ·Status: COMPLETED
-
Dissection of the Molecular and Immunological Interaction in Patients With HCC of Viral and Non-viral Etiologies
NCT05613621 ·Status: ACTIVE_NOT_RECRUITING
-
Quantitative Diagnosis of Fatty Liver by Dual Energy CT Technique
NCT00172705 ·Status: UNKNOWN
-
Risk Factors for Hepatic Inflammation, Fibrosis and Prognosis in Patients With CHB and NAFLD
NCT05766449 ·Status: RECRUITING